ClinicalTrials.gg
Not yet recruitingNCT07653529AntigravityUpdated Jun 17, 2026

Effect of Antigravity Treadmill Training on Cardiorespiratory Fitness and Lower Limb Function in Incomplete Spinal Cord Injury

An interventional study of Antigravity Treadmill for gait training and gait training and balance exercise in Incomplete Spinal Cord Injury (SCI), sponsored by Middle East University. Not yet recruiting. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-06-17.

Sponsored by Middle East University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Study summary

This study aims to investigate the effect of locomotor training using an antigravity treadmill on cardiorespiratory fitness and lower limb function in patients with incomplete spinal cord injury.

Read the detailed description

Sixty patients with incomplete spinal cord injury will be randomly assigned into two equal groups: the experimental group and the control group. Participants will be adults diagnosed with incomplete spinal cord injury classified as ASIA C or D. The experimental group will receive locomotor training using an antigravity treadmill in addition to conventional physiotherapy rehabilitation for 12 weeks. The control group will receive conventional physiotherapy rehabilitation only. The antigravity treadmill training program will be performed three sessions per week. Training intensity and body-weight support will be progressively adjusted according to patient tolerance and functional improvement.

Cardiorespiratory fitness will be evaluated using cardiopulmonary exercise testing and functional endurance assessments. Lower limb function will be assessed using gait and balance outcome measures.

02

Conditions studied

  • Incomplete Spinal Cord Injury (SCI)
03

In context

Spinal Cord Injuries

2,025 studies on the registry are indexed under Spinal Cord Injuries; 537 are open to participants now.

This study's planned enrollment of 60 is above the median of 24 across 1,633 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

Middle East University is the lead sponsor of 19 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Incomplete spinal cord injury (ASIA C or D)

  • Injury duration more than 3 months
  • Ability to stand with or without assistance
  • Medically stable condition

Exclusion criteria

Exclusion Criteria:

  • Complete spinal cord injury

    • Severe cardiopulmonary disorders
    • Severe osteoporosis or fractures
    • Severe cognitive impairment
    • Other neurological disorders affecting gait
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Study Group

    Antigravity Treadmill Training: Participants will undergo locomotor training for 30-45 minutes per session, three sessions per week, for 12 weeks. The training protocol will include: * Warm-up for 5-10 minutes * Walking training with partial body-weight support * Progressive increase in treadmill speed according to tolerance * Gradual reduction of body-weight support * Cool-down period for 5 minutes

    Device: Antigravity Treadmill for gait training · Other: gait training and balance exercise

  • Active comparator
    Control group

    Thirty patients with incomplete spinal cord injury will receive gait training between parallel bar and balance exercise

    Other: gait training and balance exercise

Interventions

  • DeviceAntigravity Treadmill for gait training

    Antigravity treadmill for gait training

  • Othergait training and balance exercise

    gait training between Parallel bar Balance Exercise

06

What researchers measure

Primary outcomes

  1. Cardiorespiratory fitness

    Cardiopulmonary fitness will be measured by Cardiopulmonary Exercise Testing (CPET) to assess the integrated function of the cardiovascular, pulmonary, and muscular systems during exercise. The gold-standard parameter obtained from CPET is: VO₂max VO₂max: Maximum rate of oxygen consumption achieved during maximal exercise. Units: mL/kg/min

    Time frame: At base line and 12 weeks

  2. Lower Limb Function

    Lower limb function will be measured by 10-Meter Walk Test (10MWT) is a simple and reliable measure of walking speed, Assesses: Gait speed Procedure Mark a 10-meter walkway. The patient will walks at: Comfortable/self-selected speed (usual gait speed) Walking Speed (m/s)= Distance (m) /Time (s)

    Time frame: At base line and 12 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07653529
Lead sponsor
Middle East University
Responsible party
Tarek Mohammed Youssef (Assistant Professor of Physiotherapy, Middle East University) — Principal investigator
First posted
Jun 17, 2026
Start date
Jun 12, 2026 (estimated)
Primary completion
Oct 12, 2026 (estimated)
Completion
Dec 15, 2026 (estimated)
Last update
Jun 17, 2026

Study contacts

Saher Lotfy Elgayar, phd
Contact
selgayar@meu.edu.jo
00962786757649

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion